ARENA PHARMACEUTICALS INC's ticker is ARNAXXXX and the CUSIP is 040047102. A total of 127 filers reported holding ARENA PHARMACEUTICALS INC in Q2 2014. The put-call ratio across all filers is 1.66 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $283,000 | +89.9% | 194,032 | +84.8% | 0.01% | +100.0% |
| Q4 2016 | $149,000 | -36.1% | 105,012 | -23.0% | 0.00% | -20.0% |
| Q2 2016 | $233,000 | +128.4% | 136,462 | +162.6% | 0.01% | +66.7% |
| Q1 2016 | $102,000 | -44.0% | 51,965 | -45.6% | 0.00% | 0.0% |
| Q4 2015 | $182,000 | +29.1% | 95,548 | +29.5% | 0.00% | +50.0% |
| Q3 2015 | $141,000 | +11.9% | 73,785 | +171.3% | 0.00% | 0.0% |
| Q2 2015 | $126,000 | -13.7% | 27,201 | -18.6% | 0.00% | -33.3% |
| Q1 2015 | $146,000 | +71.8% | 33,423 | +37.2% | 0.00% | +200.0% |
| Q4 2014 | $85,000 | -49.7% | 24,368 | -15.3% | 0.00% | -66.7% |
| Q2 2014 | $169,000 | +65.7% | 28,763 | +77.9% | 0.00% | +200.0% |
| Q1 2014 | $102,000 | +8.5% | 16,172 | +0.2% | 0.00% | 0.0% |
| Q4 2013 | $94,000 | -66.2% | 16,141 | -69.4% | 0.00% | -75.0% |
| Q3 2013 | $278,000 | – | 52,819 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MANGROVE PARTNERS IM, LLC | 867,700 | $5,085,000 | 1.68% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 4,369,066 | $25,603,000 | 1.03% |
| Lyons Wealth Management, LLC. | 56,775 | $334,000 | 0.30% |
| Callan Capital, LLC | 66,118 | $387,000 | 0.10% |
| QS BATTERYMARCH FINANCIAL MANAGEMENT, INC | 383,050 | $2,245,000 | 0.06% |
| FCG ADVISORS, LLC | 10,600 | $62,000 | 0.05% |
| OppenheimerFunds, Inc. | 7,000,000 | $41,020,000 | 0.04% |
| NEXT Financial Group, Inc | 19,704 | $86,000 | 0.04% |
| WELLINGTON MANAGEMENT GROUP LLP | 27,893,387 | $163,455,000 | 0.04% |
| MURPHY CAPITAL MANAGEMENT INC | 45,000 | $263,000 | 0.04% |